Are you Dr. Relman?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3801 Miranda Ave
154t
Palo Alto, CA 94304Phone+1 650-852-3308
Summary
- Dr. David Relman, MD is an infectious disease specialist in Palo Alto, California. He is currently licensed to practice medicine in California. He is a Professor at Stanford University Medical.
Education & Training
- Harvard Medical SchoolClass of 1982
Certifications & Licensure
- CA State Medical License 1986 - 2026
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Publications & Presentations
PubMed
- Correction: Nepali oral microbiomes reflect a gradient of lifestyles from traditional to industrialized.Erica P Ryu, Yoshina Gautam, Diana M Proctor, Dinesh Bhandari, Sarmila Tandukar
Microbiome. 2024-12-03 - 2 citationsNepali oral microbiomes reflect a gradient of lifestyles from traditional to industrialized.Erica P Ryu, Yoshina Gautam, Diana M Proctor, Dinesh Bhandari, Sarmila Tandukar
Microbiome. 2024-11-04 - Effects of parental care on skin microbial community composition in poison frogs.Marie-Therese Fischer, Katherine S Xue, Elizabeth K Costello, Mai Dvorak, Gaëlle Raboisson
Biorxiv. 2024-10-13
Press Mentions
- NIH Cancels ‘Havana Syndrome’ Research, Citing Unethical Coercion of ParticipantsSeptember 1st, 2024
- Theodor Diener, Who Discovered the Tiniest of Infectious Agents, Dies at 102May 8th, 2023
- Monday, Feb 27 2023February 27th, 2023
- Join now to see all
Grant Support
- Applied Genomics in Infectious DiseasesSTANFORD UNIVERSITY1995–2027
- Household transmission of the human gut microbiota after antibiotic exposureSTANFORD UNIVERSITY2022–2025
- Antimicrobial Resistance and Horizontal Gene Transfer in the Human Gut Microbiome in Response to an AntibioticPALO ALTO VETERANS INSTIT FOR RESEARCH2020–2025